CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-09 | Mohindru Mani Director | Grant or award · Stock Options | +26,800 | 70,801 | ||
| 2022-03-09 | Markin Rodney S Director | Grant or award · Stock Options | +26,800 | 124,627 | ||
| 2022-03-09 | Levine James E. Chief Financial Officer | Grant or award · Stock Options | +170,016 | 560,016 | ||
| 2022-03-09 | Kelemen Vicki Exec. VP and COO | Grant or award · Stock Options | +170,016 | 572,784 | ||
| 2022-03-09 | Erlander Mark Chief Executive Officer | Grant or award · Stock Options | +370,128 | 1,185,400 | ||
| 2022-03-09 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +26,800 | 125,317 | ||
| 2022-03-09 | Armitage James O Director | Grant or award · Stock Options | +26,800 | 89,574 | ||
| 2021-09-21 | PACE GARY W Director | Purchase | +30,000 | $6.75 | $203K | 494,811 |
| 2021-09-10 | Levine James E. Chief Financial Officer | Purchase | +5,000 | $6.62 | $33K | 5,000 |
| 2021-09-10 | Levine James E. Chief Financial Officer | Purchase | +5,000 | $6.75 | $34K | 10,000 |
| 2021-09-10 | Levine James E. Chief Financial Officer | Purchase | +10,000 | $6.38 | $64K | 20,000 |
| 2021-09-10 | Levine James E. Chief Financial Officer | Purchase | +5,000 | $6.35 | $32K | 25,000 |
| 2021-09-10 | Levine James E. Chief Financial Officer | Purchase | +5,000 | $6.32 | $32K | 30,000 |
| 2021-07-12 | Ruffner Katherine L Chief Medical Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2021-07-12 | Levine James E. Chief Financial Officer | Grant or award · Common Stock | +390,000 | 390,000 | ||
| 2021-06-10 | JACOB GARY S Former Director | Other acquisition · Stock Options | +28,858 | 76,106 | ||
| 2021-06-10 | JACOB GARY S Former Director | Other acquisition · Stock Options | +293 | 76,106 | ||
| 2021-06-10 | JACOB GARY S Former Director | Other acquisition · Stock Options | +218 | 76,106 | ||
| 2021-06-10 | JACOB GARY S Former Director | Other acquisition · Stock Options | +223 | 76,106 | ||
| 2021-06-10 | JACOB GARY S Former Director | Other acquisition · Stock Options | +223 | 76,106 |
Page 5 of 8 · 144 trades